Date of event
Thursday, March 26, 2020 - 5:00 pm -
Thursday, March 26, 2020 - 6:00 pm
Continuing Education Credits

Content Contributor

AASLD COVID-19 Working Group Members


  • Oren K. Fix, MD, MSc, FAASLD
  • Bilal Hameed, MD

Moderators / Presenters

  • Raymond T. Chung, MD, FAASLD
  • K. Rajender Reddy, MD, FAASLD


  • Robert J. Fontana, MD, FAASLD
  • Ryan M. Kwok, MD
  • Brendan M. McGuire, MD
  • David C. Mulligan, MD, FAASLD
  • Daniel S. Pratt, MD, FAASLD
  • Mark W. Russo, MD, MPH, FAASLD
  • Michael L. Schilsky, MD, FAASLD
  • Jorge A. Bezerra, MD, FAASLD


As the COVID-19 pandemic continues to evolve, AASLD is committed to helping our members and the broader community respond to increasing challenges and complexities. Recorded March 26, 2020, this webinar highlighted information from AASLD’s "Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic" paper.

For More Information

Visit AASLD's "COVID-19 and the Liver" resources page.

Watch the webinar / download the presentation

Download the slide presentation.

Presenter Bios

Oren K. Fix, MD, MSc, FAASLD

Dr. Oren Fix is the Medical Director of the Liver Transplant Program at Swedish Medical Center in Seattle, Washington and Clinical Associate Professor at the Washington State University Elson S. Floyd College of Medicine. He is an Associate Provider Informaticist at Providence St. Joseph Health and is board certified in Clinical Informatics and an Epic Physician Builder. He has served the AASLD as chair of the Training and Workforce and MOC Committees and currently serves on the Nominating Committee, Online Learning Committee, and the GI/Transplant Hepatology Pilot Steering Task Force. He is on the editorial boards of Liver Transplantation and Hepatology Communications. His research interests include alcohol-associated hepatitis and acute liver failure and he has more than 50 peer-reviewed publications and book chapters.

photo of Dr. Oren Fix

Bilal Hameed, MD

Dr. Bilal Hameed is the Associate Professor of Medicine and the Hepatology Clinic Chief at the University of California, San Francisco. He is the section editor for the journal Gastroenterology. He is a board member of the Northern California Society for Clinical Gastroenterology. He has authored more than 30 original articles, reviews and book chapters on NASH and ALF in various prestigious journals. He is the PI for Acute Liver Failure Study Group (ALFSG) and co-investigator on an NIH-funded study on NASH. He is an investigator on several ongoing clinical trials for patients with NASH, PSC and chronic liver diseases. He is recognized nationally and internationally for his work related to Nonalcoholic Steatohepatitis (NASH) and Acute Liver Failure (ALF).

photo of Dr. Hameed

Moderator Bios

Raymond T. Chung, MD, FAASLD [AASLD President-Elect]

Dr. Raymond Chung is Director of Hepatology and the Liver Center, Vice Chief of Gastroenterology and the Kevin and Polly Maroni Research Scholar at Massachusetts General Hospital. He has been an internationally recognized researcher in the areas of HCV virology and pathogenesis. He directs an NIH Cooperative Center for Human Immunology centered on HCV, and is co-PI of the Harvard HBV Consortium of the NIH HBV Research Network. He is contact PI of his Divisional T32 Training Grant, and holds several NIH R01 grants and an NIH K24 Mentorship Award.

He was recently Associate Editor of HEPATOLOGY and has previously served as a Councilor at Large for the AASLD. He has also served as co-Chair of the AASLD/IDSA HCV Guidance panel which is charged with issuing treatment recommendations for hepatitis C. He has authored more than 300 original articles, reviews, and editorials.

photo of Dr. Ray Chung

K. Rajender Reddy, MD, FAASLD

Dr. Reddy is the Ruimy Family President’s Distinguished Professor of Medicine and Professor of Medicine in Surgery in the Division of Gastroenterology/Hepatology at the University of Pennsylvania. He is the Director of Hepatology, Medical Director of Liver Transplantation, and the Director of the Viral Hepatitis Center. He is a Fellow of the American College of Physicians, American College of Gastroenterology, the Royal College of Physicians, and the American Association for the Study of Liver Diseases. He has held several Visiting Professorships at medical schools throughout the world. He has trained and mentored, over the years, several fellows and research assistants, towards a career path in health care and research. He served on several committees for AASLD and was a Councilor-at-Large for three years. Dr. Reddy was also a recipient of AASLD’s Distinguished Educator/Mentor Award in 2019.

Dr. Reddy has authored or co-authored several papers on a spectrum of hepatobiliary topics that include liver transplantation, chronic C viral hepatitis, acute on chronic liver failure, and hepatocellular carcinoma. In addition, he has edited and contributed to several text books, and has participated in numerous scientific presentations at national and international meetings. He has been the recipient of both federal and non-federal funding for clinical research.

photo of Dr. Reddy